The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these therapies, and a surge in the number of CLK inhibitors currently in clinical development. LAS VEGAS, Aug 6, 2025 /PRNewswire/ –…
